These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 39045646)

  • 1. The evolution and ongoing challenge of unproven cell-based interventions.
    Brinsfield TN; Pinson NR; Levine AD
    Stem Cells Transl Med; 2024 Sep; 13(9):851-858. PubMed ID: 39045646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spotting 'unproven' stem cell therapies in the wild.
    Leask F
    Biotechniques; 2019 Dec; 67(6):253-255. PubMed ID: 31687832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and emerging global themes in the bioethics of regenerative medicine: the tangled web of stem cell translation.
    Chan S
    Regen Med; 2017 Oct; 12(7):839-851. PubMed ID: 29119870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unproven stem cell-based interventions & physicians' professional obligations; a qualitative study with medical regulatory authorities in Canada.
    Zarzeczny A; Clark M
    BMC Med Ethics; 2014 Oct; 15():75. PubMed ID: 25315976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unproven stem cell-based interventions and achieving a compromise policy among the multiple stakeholders.
    Matthews KR; Iltis AS
    BMC Med Ethics; 2015 Nov; 16(1):75. PubMed ID: 26537611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How do I: Evaluate the safety and legitimacy of unproven cellular therapies?
    Guleria I; de Los Angeles Muñiz M; Wilgo M; Bapat A; Cui W; Hsu YS; Jeyaraman M; Muthu S; Rodriguez F; Fesnak A; Celluzzi C; Sesok-Pizzini D; Reich-Slotky R; Spitzer T
    Transfusion; 2022 Mar; 62(3):518-532. PubMed ID: 35143051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory and policy tools to address unproven stem cell interventions in Canada: the need for action.
    Caulfield T; Murdoch B
    BMC Med Ethics; 2019 Aug; 20(1):51. PubMed ID: 31383026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions.
    Bauer G; Elsallab M; Abou-El-Enein M
    Stem Cells Transl Med; 2018 Sep; 7(9):676-685. PubMed ID: 30063299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles and responsibilities of physicians in patients' decisions about unproven stem cell therapies.
    Levine AD; Wolf LE
    J Law Med Ethics; 2012; 40(1):122-34. PubMed ID: 22458467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioethics of Clinical Applications of Stem Cells.
    Petrini C
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives.
    Rahimi Darehbagh R; Seyedoshohadaei SA; Ramezani R; Rezaei N
    Eur J Med Res; 2024 Jul; 29(1):386. PubMed ID: 39054501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The involvement of Canadian physicians in promoting and providing unproven and unapproved stem cell interventions.
    Ogbogu U; Du J; Koukio Y
    BMC Med Ethics; 2018 May; 19(1):32. PubMed ID: 29716594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulated, reliable, and reputable: Protect patients with uniform standards for stem cell treatments.
    Lomax GP; Torres A; Millan MT
    Stem Cells Transl Med; 2020 May; 9(5):547-553. PubMed ID: 32040254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bench-to-bedside translation of stem cell therapies: where are we now and where are we going?
    Martino G
    Regen Med; 2016 Jun; 11(4):347-9. PubMed ID: 27188381
    [No Abstract]   [Full Text] [Related]  

  • 16. International stem cell tourism and the need for effective regulation. Part I: Stem cell tourism in Russia and India: clinical research, innovative treatment, or unproven hype?
    Cohen CB; Cohen PJ
    Kennedy Inst Ethics J; 2010 Mar; 20(1):27-49. PubMed ID: 20506693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory loophole enables unproven autologous cell therapies to thrive in Australia.
    Munsie M; Pera M
    Stem Cells Dev; 2014 Dec; 23 Suppl 1():34-8. PubMed ID: 25457959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unproven stem cell interventions: A global public health problem requiring global deliberation.
    Master Z; Matthews KRW; Abou-El-Enein M
    Stem Cell Reports; 2021 Jun; 16(6):1435-1445. PubMed ID: 34107243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Representations of stem cell clinics on Twitter.
    Kamenova K; Reshef A; Caulfield T
    Stem Cell Rev Rep; 2014 Dec; 10(6):753-60. PubMed ID: 24970380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracking the rise of stem cell tourism.
    Ryan KA; Sanders AN; Wang DD; Levine AD
    Regen Med; 2010 Jan; 5(1):27-33. PubMed ID: 20017692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.